Archive | October, 2011

Clinical Data and Biospecimens available for over 200 subjects

With over 200 PPMI subjects enrolled, the clinical data and biospecimens is robust and available in real time. The goal of PPMI is to validate biomarkers of PD progression. The cornerstone of this study is making the data and samples collected available to the scientific community.

Continue reading...

Dr. Irene Richard talks PPMI on WHAM ABC 13

WHAM ABC 13 speaks with Dr. Irene Richard, PI at the University of Rochester, about the unique aspects of PPMI and working with The Michael J. Fox Foundation.

Continue reading...

Johns Hopkins PI featured on WBFF Fox45

Dr. Zoltan Mari, PI at John Hopkins University, was interviewed on WBFF Fox45. Dr. Mari talked about PPMI, and provided general information on biomarkers and the progression of Parkinson's disease.

Continue reading...

PPMI Diffusion Tensor Imaging Sub-study One of the Largest Ever in PD

In addition to collecting structural MRI data, seven PPMI sites will also be performing diffusion tensor imaging (DTI), an MRI technique that analyzes the movement of water molecules in brain tissue.  Several groups have reported DTI differences in PD patients that may be associated with disease progression. The seven PPMI sites that were selected for […]

Continue reading...